Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

9.85
Delayed Data
As of Jul 22
 -0.11 / -1.10%
Today’s Change
5.90
Today|||52-Week Range
13.18
-5.83%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Cytokinetics Inc have a median target of 19.00, with a high estimate of 24.00 and a low estimate of 14.00. The median estimate represents a +92.89% increase from the last price of 9.85.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Cytokinetics Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.31
Sales
$10.2M
Reporting Date
Jul 27

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 1.07%
 
 
 
 
 
 
Growthannually -54.98%
 
 
 
 
 
 

Sales

Growthquarterly 20.53%
 
 
 
 
 
 
Growthannually 14.90%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.